M&A · Healthcare · Buyer's industry: Pharmaceutical Preparations
Sesen Bio, Inc. to acquire Carisma Therapeutics
Announced Sep 21, 2022 · Closed Mar 8, 2023 · Private target
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll stock
Transaction
- Acquirer
- Sesen Bio, Inc. (SESN)
- Target
- Carisma Therapeutics
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Closed Mar 8, 2023
Deal protections
Not disclosed for private-company acquisitions.
Advisors
- To the acquirer
- Leerink Partners
- To the target
- Evercore, BofA Securities
Classification
- Sector
- Healthcare
- Buyer's industry
- Pharmaceutical Preparations